Day: February 25, 2026

Novo Nordisk to Cut US List Prices of Wegovy and Ozempic by Up to 50% Starting 2027

Key Highlights Novo Nordisk Announces Major US Price Cuts Novo Nordisk will significantly reduce the US list prices of its blockbuster weight-loss and diabetes drugs beginning January 1, 2027. The Danish pharmaceutical giant confirmed that Wegovy’s list price will fall by 50% to $675 per month, while Ozempic will see a 35% reduction. The revised